Lonza Group reported 3.11B in Current Liabilities for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Akzo Nobel AKZA:NA € 3850M 619M
AstraZeneca AZN:LN 22222M 709M
BASF BAS:GR € 19534M 423M
Bayer BAYN:GR € 27926M 1006M
Covestro 1COV:GR 3.41B 787M
DSM DSM:NA € 2264M 82M
Fresenius FRE:GR € 15204M 743M
Fresenius Medical Care FME:GR € 7425M 182M
Genmab GEN:DC DK 1351M 58M
Givaudan GIVN:VX 2.41B 618M
GlaxoSmithKline GSK:LN 21387M 1112M
GN Store Nord GN:DC DK 4575M 64M
H. Lundbeck A/S LUN:DC 8.44B 474M
Hikma Pharmaceutical HIK:LN 960M 68M
Johnson Matthey JMAT:LN 3.6B 592M
Merck MRK:GR € 9820M 832M
Novartis NOVN:VX SF 29633M 527M
Solvay SOLB:BB € 3285M 4M
William Demant Holding WDH:DC 9.47B 2.1B